Skip to content

Treacher Collins syndrome: Genectis and OSAS

Treacher Collins syndrome: Genectis and OSAS - Treacher Collins Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33933
Enrollment
43
Registered
2009-03-03
Start date
2009-09-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Syndrome (OSAS) Treacher Collins Syndrome

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Treacher Collins Syndrome diagnosis - Treated in the Erasmus MC, University Medical Center craniofacial center - Informed consent - Dutch-speakers who are able to answer the questions in the questionnaires

Exclusion criteria

Exclusion criteria: - Patients who are not able to speak and understand Dutch

Design outcomes

Primary

MeasureTime frame
1. Newly found yet undiscoverd mutations in the TCOF1 gene 2. OSAS parameters will be defined in this TCS population and the natural course, severity, prevalence and potential metabolic and physical effects of OSAS in this population will be determined.

Secondary

MeasureTime frame
1. length, weight and bloodpressure will be determined in the TCS population

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)